UCLA Medical Center Gynecologic Oncology

Topics

• Ovarian cancer diagnosis and treatment 605
• Endometrial and Cervical Cancer Treatments 343
• BRCA gene mutations in cancer 109
• Cervical Cancer and HPV Research 101
• PARP inhibition in cancer therapy 84
• Uterine Myomas and Treatments 47
• Economic and Financial Impacts of Cancer 41
• Prostate Cancer Diagnosis and Treatment 35
• HER2/EGFR in Cancer Research 31
• Breast Cancer Treatment Studies 28
• Glycosylation and Glycoproteins Research 28
• Cancer Risks and Factors 27

Most cited

1. FIGO staging of endometrial cancer: 2023.

   International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2023 · 869 citations · Jonathan Berek

2. Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.

   The New England journal of medicine · 2023 · 703 citations · Dana Chase

3. Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 486 citations · Ritu Salani

4. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 914 citations · Beth Karlan

5. NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 349 citations · Ritu Salani

6. Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.

   The New England journal of medicine · 2023 · 405 citations · Gottfried E. Konecny